Moreover, hypoglycemia is a frequent side effect of therapeutic treatment with insulin, sulfonylureas or glinides, while other treatments (metformin, acarbose, thiazolidinediones, GLP-1 receptor agonists, and DPP-4 inhibitors) are capable of reducing hyperglycemia without inducing hypoglycemia
In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation , MDL 3163, currently has 29 plaintiffs alleging that GLP-1 RA drugs caused them to develop non-arteritic anterior ischemic optic neuropathy (NAION)
In other words, Big Pharma isnt protecting actual innovation, but gaming the patent system to block competition, keep prices high, and boost profits
Consultation costs vary: primary care visits are typically $100-250 without insurance (often covered by insurance with copay), specialist visits run $200-400 without insurance, and telehealth consultations typically cost $50-150
336,337 The inhibitors of IDO are currently under investigation in clinical trials for solid cancer to enhance primary anticancer therapy, including antibodies and immune checkpoint inhibitors
A redox cycle within the cell cycle: ring in the old with the new
